BEST PRACTICES in Managing FGFRi Treatment–Related AEs: Intrahepatic Cholangiocarcinoma

This article is funded by Taiho Oncology, Inc. The publisher is solely responsible for this content. Taiho does not recommend or endorse the use of its products other than as described in the approved labeling. The content of this article is not medical advice, and does not replace independent medical judgment.